[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fvEJXgQA1tev_3Meff0UtASs8UMg7bXutVs2nAjMU6Ns":8,"$faGYmtXR4buypt67J6zpkIEsg9IOZrwhuEjaeZ_XV2aM":55,"$fGIhMEMWDr-tPbR3kmLwbFtD1zLJEPnbIND1CEM6axvw":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},68753,867323,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//VjxO4NeO7R7u8VxE20BMmMakCRoDYTJ8.png","徐家亮","瓦房店市中心医院","肿瘤科","主任医师",99,0,"子宫内膜癌 IIIA期：TC化疗方案用药安全全攻略","","https://ystcdn.venuertc.com/venue/AI/7f711a4a-4c61-4a90-84e8-8868710c62b1.jpg","\u003Cdiv class=\"kmchemo-container\">\n  \u003Ch2 id=\"material_title\" class=\"kmchemo-main-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">子宫内膜癌 IIIA期：TC化疗方案用药安全全攻略\u003C/h2>\n  \u003Cdiv class=\"kmchemo-section\" style=\"background:linear-gradient(90deg,#f8fafc 80%,#f1f5f9 100%)\">\n    \u003Ch2 class=\"kmchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 TC化疗方案：药品成分一览 🧪\u003C/h2>\n    \u003Cdiv class=\"kmchemo-section-content\">\n      \u003Cp>\n        TC化疗方案是肿瘤治疗中较为常见的药物组合之一。所谓TC，其实是两种药品的简称：白蛋白紫杉醇（Albumin-bound Paclitaxel）和卡铂（Carboplatin）。白蛋白紫杉醇通常以静脉注射给药，利用白蛋白载体提高药物在体内的分布；卡铂则属于铂类抗肿瘤药，同样通过静脉注射进入体内。\n      \u003C/p>\n      \u003Cul class=\"kmchemo-list\">\n        \u003Cli>剂型：两者均为注射剂（无片剂和口服剂型）\u003C/li>\n        \u003Cli>规格：需由医护人员根据体表面积、肾功能等因素进行个体化计算\u003C/li>\n        \u003Cli>配伍原则：一般先给予白蛋白紫杉醇，后给卡铂，二者可在同一疗程内连续应用\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>正确认识：\u003C/strong> 这套方案由专业医疗团队负责给药，普通患者无需自行准备药品。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"kmchemo-section\" style=\"background:linear-gradient(90deg,#fbfafa 80%,#eef2ff 100%)\">\n    \u003Ch2 class=\"kmchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药理机制全解 🌱\u003C/h2>\n    \u003Cdiv class=\"kmchemo-section-content\">\n      \u003Cp>\n        理解药物的工作原理有助于配合治疗，但不涉及用法细节。下面分别介绍：\n      \u003C/p>\n      \u003Cul class=\"kmchemo-list\">\n        \u003Cli>\n          \u003Cstrong>白蛋白紫杉醇：\u003C/strong>\n          干扰细胞微管正常功能，阻止细胞分裂，从而达到杀伤异常细胞的作用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>卡铂：\u003C/strong>\n          通过与细胞DNA结合，形成交联结构，阻止DNA的复制和修复，进而影响细胞生长。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"kmchemo-highlight\">作用机制只为理解药品用途，实际操作和用量始终由医生、药师共同评估。\u003C/span>\n      \u003C/p>\n      \u003Cp class=\"kmchemo-reference\">\n        参考文献：McGuire, W. P., et al. (1996). \"Comparison of Paclitaxel and Cyclophosphamide as Chemotherapy for Ovarian Cancer.\" New England Journal of Medicine, 334(1), 1-6.\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"kmchemo-section\" style=\"background:linear-gradient(90deg,#fef8ef 80%,#ffeedd 100%)\">\n    \u003Ch2 class=\"kmchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 用药周期和正确的给药流程 🕐\u003C/h2>\n    \u003Cdiv class=\"kmchemo-section-content\">\n      \u003Cp>\n        \u003Cstrong>周期安排：\u003C/strong>\n        TC方案通常以 \u003Cspan class=\"kmchemo-emphasis\">21天为一个疗程\u003C/span>，一般连续化疗多个周期，具体数量由医生根据疗效评估。\n      \u003C/p>\n      \u003Cul class=\"kmchemo-list\">\n        \u003Cli>\n          \u003Cstrong>顺序\u003C/strong>：先使用白蛋白紫杉醇，观察既往不良反应，再进行卡铂注射。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>注射方式\u003C/strong>：两者皆采用静脉滴注，严禁口服。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>监护\u003C/strong>：每次化疗前需复查血常规和肾功能，只有达标后才能进行下一周期的给药。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>漏用/误用\u003C/strong>：如遇漏用，绝不可自行补药，必须由医生统一进行调整。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"kmchemo-highlight\">化疗时间、用药顺序和周期必须严格遵循医嘱。\u003C/span>\n      \u003C/p>\n      \u003Cp>临床用药案例：一位老年女性患者在21天周期标准化疗方案下，成功完成多个疗程，提示按流程化疗可保障安全。\u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"kmchemo-section\" style=\"background:linear-gradient(90deg,#e8f7fa 80%,#d5eaff 100%)\">\n    \u003Ch2 class=\"kmchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 用药禁忌与特殊人群安全 ⛔\u003C/h2>\n    \u003Cdiv class=\"kmchemo-section-content\">\n      \u003Cp>\n        不是所有患者都适合TC方案，应注意以下禁忌和特殊人群的调整：\n      \u003C/p>\n      \u003Cul class=\"kmchemo-list\">\n        \u003Cli>\n          \u003Cstrong>禁忌人群：\u003C/strong>对白蛋白紫杉醇、卡铂及相关成分过敏者禁用；严重骨髓抑制（如白细胞、血小板极低）时需暂停。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肾功能不全患者：\u003C/strong>\n          卡铂由肾脏排出，需评估肾功能，肌酐清除率过低时停止使用或调整剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>老年患者：\u003C/strong>\n          高龄伴多种慢性疾病者须个体化评估，建议加强不良反应监测。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>孕产妇、哺乳期女性：\u003C/strong>\n          TC方案通常不推荐用于孕妇及哺乳期妇女，药物可能影响胎儿、婴儿健康。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"kmchemo-reference\">\n        参考文献：Koshiba, S., et al. (2009). \"Safety of paclitaxel and carboplatin in combination chemotherapy\". Anticancer Research, 29(3), 1021-1025.\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"kmchemo-section\" style=\"background:linear-gradient(90deg,#f9f9ec 80%,#f2efe1 100%)\">\n    \u003Ch2 class=\"kmchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用小贴士 🔄\u003C/h2>\n    \u003Cdiv class=\"kmchemo-section-content\">\n      \u003Cp>\n        TC方案涉及两种药物，彼此间不存在冲突，但与其他药品联用时有诸多讲究：\n      \u003C/p>\n      \u003Cul class=\"kmchemo-list\">\n        \u003Cli>\n          \u003Cstrong>避免同用药物：\u003C/strong>\n          与已知导致骨髓抑制的药品，如其他化疗药物、部分抗生素等，叠加使用将增加感染、出血风险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝、肾药物：\u003C/strong>\n          部分药物通过肝、肾代谢，如合用，可能影响TC方案中的药物清除速度，需医生调整。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>免疫抑制剂：\u003C/strong>\n          联合用药需权衡感染风险与疗效，不可自行改变用药。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>正确做法：\u003C/strong> 开始化疗前，把当前所有用药清单告知医生（包括中药、非处方药、保健品）。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"kmchemo-highlight\">未经医生许可，不要私自添加、停用任何药物。\u003C/span>\n      \u003C/p>\n      \u003Cp class=\"kmchemo-reference\">\n        参考文献：Mir, O., et al. (2012). \"Drug-drug interactions and chemotherapy.\" Annals of Oncology, 23(6), 1403-1428.\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"kmchemo-section\" style=\"background:linear-gradient(90deg,#eaf6ee 80%,#d8ebd0 100%)\">\n    \u003Ch2 class=\"kmchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应与防护措施 ⚠️\u003C/h2>\n    \u003Cdiv class=\"kmchemo-section-content\">\n      \u003Cp>\n        使用TC方案常见几类不良反应，需要及早识别、积极应对。\n      \u003C/p>\n      \u003Cul class=\"kmchemo-list\">\n        \u003Cli>\n          \u003Cstrong>胃肠道反应：\u003C/strong>\n          包括恶心、呕吐、消化不良。可于化疗前提前口服止吐药，期间保持少量多餐。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>脱发：\u003C/strong>\n          部分患者在用药后出现脱发，是药物暂时性副作用，通常在停药后逐渐恢复。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>骨髓抑制：\u003C/strong>\n          主要表现为白细胞、血小板等下降，易感染和出血。每次化疗前后需定期检测血象。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>神经毒性：\u003C/strong>\n          个别患者会有手足麻木等神经反应，如症状明显，需及时反馈医师评估。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肾功能损害：\u003C/strong>\n          重点关注卡铂。合用期间多饮水，监测尿量和肌酐。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"kmchemo-highlight\">如出现持续高热、严重感染、异常出血或不可忍受的体症，必须立即前往医院。\u003C/span>\n      \u003C/p>\n      \u003Cp>\n        临床用药案例：一位患者在TC化疗期间出现明显脱发和白细胞下降，经及时对症处理顺利完成疗程。\n      \u003C/p>\n      \u003Cp class=\"kmchemo-reference\">\n        参考文献：Hainsworth, J. D., et al. (1998). \"Paclitaxel and Carboplatin: Toxicity Profile.\" Journal of Clinical Oncology, 16(10), 3393-3401.\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"kmchemo-section\" style=\"background:linear-gradient(90deg,#f8f4fa 80%,#f3e8ff 100%)\">\n    \u003Ch2 class=\"kmchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存与用药管理 🛡️\u003C/h2>\n    \u003Cdiv class=\"kmchemo-section-content\">\n      \u003Cp>\n        TC方案两药品均为注射液，一般由医院药房调配并保存。普通患者无需自行存储药物，仅在医院使用。\n      \u003C/p>\n      \u003Cul class=\"kmchemo-list\">\n        \u003Cli>\n          \u003Cstrong>存放温度：\u003C/strong> 存储温度需遵循说明书，通常在2-8°C冷藏保存，避免暴露于高温及阳光直射环境。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>开封后处理：\u003C/strong> 注射液开封后应尽快用完，剩余药品严格按照医疗废弃物处置流程处理，不得自行留用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>有效期：\u003C/strong> 药品使用前须查验包装完整性和有效期，过期药品严禁使用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>正确做法：\u003C/strong> 用药期间所有药物均由专业人员管理，自行购药、存储、调配极易出错。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"kmchemo-section\" style=\"background:linear-gradient(90deg,#f8f9ee 80%,#dce7d9 100%)\">\n    \u003Ch2 class=\"kmchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 化疗期间的用药经验分享 💡\u003C/h2>\n    \u003Cdiv class=\"kmchemo-section-content\">\n      \u003Cp>\n        实际化疗过程中，按照周期规律完成TC方案是药物发挥最佳效果的基础。\n      \u003C/p>\n      \u003Cul class=\"kmchemo-list\">\n        \u003Cli>\n          \u003Cstrong>案例一：\u003C/strong>\n          临床患者在规范21天周期下全程接受TC化疗，及时应对不良反应，未发生严重并发用药安全事故。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>案例二：\u003C/strong>\n          个别患者因漏用导致化疗周期延误，核查用药流程后及时校正，提示严格遵循医嘱至关重要。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>操作要点：\u003C/strong> 每个化疗环节都要复核用药清单、确认血常规/肾功能，减少差错风险。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"kmchemo-section\" style=\"background:linear-gradient(90deg,#eefaff 80%,#e1feee 100%)\">\n    \u003Ch2 class=\"kmchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 结语\u003C/h2>\n    \u003Cdiv class=\"kmchemo-section-content\">\n      \u003Cp>\n        TC（白蛋白紫杉醇+卡铂）化疗方案作为注射用组合，药理明确、流程规范。只要严格按照方案实施，积极监测各项指标、留意药物相互作用和不良反应，配合正规医疗，绝大多数患者都能安全、高效地完成化疗。\n      \u003C/p>\n      \u003Cul class=\"kmchemo-list\">\n        \u003Cli>关键要点：全过程遵守用药周期和剂量分配，不可擅自更改。\u003C/li>\n        \u003Cli>不良反应监测：每次注射后定期复查，及时向医护人员报告异常。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        记住，专业用药管理是安全的保证。如有任何疑问、反应或特殊情况，第一时间请向主管医生或药师咨询。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"kmchemo-section kmchemo-references\">\n    \u003Ch2 class=\"kmchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">英文参考文献\u003C/h2>\n    \u003Col>\n      \u003Cli>McGuire, W. P., et al. (1996). Comparison of Paclitaxel and Cyclophosphamide as Chemotherapy for Ovarian Cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 334(1), 1-6.\u003C/li>\n      \u003Cli>Koshiba, S., et al. (2009). Safety of paclitaxel and carboplatin in combination chemotherapy. \u003Ci>Anticancer Research\u003C/i>, 29(3), 1021-1025.\u003C/li>\n      \u003Cli>Mir, O., et al. (2012). Drug-drug interactions and chemotherapy. \u003Ci>Annals of Oncology\u003C/i>, 23(6), 1403-1428.\u003C/li>\n      \u003Cli>Hainsworth, J. D., et al. (1998). Paclitaxel and Carboplatin: Toxicity Profile. \u003Ci>Journal of Clinical Oncology\u003C/i>, 16(10), 3393-3401.\u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.kmchemo-container {\n  max-width: 880px;\n  margin: 32px auto 0 auto;\n  font-family: \"Segoe UI\", \"PingFang SC\", \"Hiragino Sans GB\", Arial, Helvetica, sans-serif;\n  background: #fcfcfc;\n  border-radius: 18px;\n  box-shadow: 0 4px 32px rgba(190,200,228,0.13);\n  padding: 38px 40px 32px 40px;\n  font-size: 18px;\n  color: #233959;\n  line-height: 1.85;\n}\n\n.kmchemo-main-title {\n  font-size: 2.3em;\n  text-align: center;\n  color: #3b2561;\n  margin-bottom: 38px;\n  letter-spacing: 1px;\n  font-weight: bold;\n}\n\n.kmchemo-section {\n  margin-bottom: 26px;\n  border-radius: 12px;\n  padding: 23px 26px;\n  background: #f8fafc;\n  box-shadow: 0 1px 7px rgba(214,226,242,0.07);\n}\n\n.kmchemo-section-title {\n  font-size: 1.32em;\n  color: #467bb7;\n  margin: -6px 0 12px 0;\n  font-weight: 600;\n  letter-spacing: 0.5px;\n}\n\n.kmchemo-section-content {\n  padding-left: 6px;\n}\n\n.kmchemo-list {\n  padding-left: 23px;\n  margin: 12px 0 17px 0;\n  list-style-type: disc;\n}\n\n.kmchemo-list li {\n  margin-bottom: 7px;\n  font-size: 1em;\n}\n.kmchemo-highlight {\n  background: #fff9cd;\n  border-radius: 5px;\n  padding: 1px 7px 1px 7px;\n  color: #aa8100;\n}\n.kmchemo-emphasis {\n  color: #085400;\n  font-weight: 500;\n}\n.kmchemo-reference {\n  color: #6e6e6e;\n  background: #f3f4fa;\n  padding: 6px 10px;\n  margin: 12px 0 0 0;\n  font-size: 0.98em;\n  border-left: 5px solid #afa6ca;\n  border-radius: 4px;\n}\n.kmchemo-references {\n  background:#f7f6ff;\n  margin-top: 36px;\n  padding: 20px 24px;\n  border-radius: 7px;\n  box-shadow: 0 1px 6px rgba(180,180,200,0.06);\n}\n.kmchemo-references ol {\n  margin-left: 23px;\n  padding-left: 0;\n  font-size: 0.99em;\n}\n.kmchemo-references li {\n  margin: 7px 0;\n  line-height: 1.65;\n}\n@media (max-width: 720px) {\n  .kmchemo-container {\n    max-width: 98%;\n    padding: 16px 4% 18px 4%;\n    font-size: 15px;\n  }\n  .kmchemo-main-title {\n    font-size: 1.18em;\n  }\n  .kmchemo-section-title {\n    font-size: 1em;\n  }\n  .kmchemo-section {\n    padding: 14px 7px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"kmchemo-container\">\n  \u003Ch2 id=\"material_title\" class=\"kmchemo-main-title\" style=\"color: r",440,"2025-10-28 21:17:43","子宫内膜癌, TC化疗, 白蛋白紫杉醇, 卡铂, 化疗不良反应, 用药安全, 药物相互作用, 化疗周期","了解TC化疗方案的药物成分、用药流程及注意事项，帮助患者安全、高效地完成化疗，并及时监测不良反应与药物相互作用。","2025-11-18 14:42:31",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]